Literature DB >> 23516187

Genome Sequence of the Group III Clostridium botulinum Strain Eklund-C.

Karl A Hassan1, Sasha G Tetu, Liam D H Elbourne, Eric A Johnson, Ian T Paulsen.   

Abstract

The neurotoxins produced by Clostridium botulinum strains are among the world's most potent toxins and are the causative agents of paralytic botulism. Here, we present the draft genome sequence of the group III C. botulinum strain Eklund-C, including a pseudolysogen-like bacteriophage that harbors the type C neurotoxin operon.

Entities:  

Year:  2013        PMID: 23516187      PMCID: PMC3622972          DOI: 10.1128/genomeA.00044-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Clostridium botulinum strains are formidable human and animal pathogens that produce botulinum neurotoxin (BoNT), the most potent neurotoxin described to date and the causative agent of botulism. Animal botulism cases are commonly associated with group III C. botulinum strains, which harbor type C or D BoNT genes. Here, we report the draft genome sequence of the prototypical C. botulinum group III BoNT/C-producing Eklund strain (Eklund-C). Genomic DNA was sequenced using a Sanger shotgun method to 8-fold coverage and was assembled and annotated as described previously (1). The assembled genome sequence contains 2.96 Mb of sequence data containing 2,578 putative protein-coding genes, 251 putative pseudogenes, and 126 structural RNA genes. Group III C. botulinum strains are phylogenetically related to strains Clostridium novyi and Clostridium haemolyticum (2, 3). Genome sequences for two strains within this phylogenetic group have been published, those of C. botulinum C/D 08-BKT015925 (4) and C. novyi NT (5, 6). Approximately 75 to 78% of the annotated protein-coding genes or pseudogenes within the Eklund-C strain were conserved in the 08-BKT015925 and NT strains, that is, 2,206 and 2,132 genes or pseudogenes, respectively, as determined using tBLASTx 2.2.25+ (7) searches (E value ≤1e - 30). Furthermore, the majority of the Eklund-C scaffold sequences could be aligned to the 08-BKT015925 and NT chromosomal sequences using Mauve 2.3.1 (8), highlighting the synteny among the three genomes. A primary differentiating factor between the toxigenic group III C. botulinum strains and closely related species, such as C. novyi, is their carriage of BoNT/C or BoNT/D genes on an episomal pseudolysogen-like prophage (9, 10). Five scaffolds containing a total of 177 kb of sequence data are predicted to comprise the Eklund-C BoNT/C bacteriophage genome, which can be aligned to the BoNT/C-encoding phage isolated from strains C. botulinum 08-BKT015925 (4) and C. botulinum C-Stockholm (11). The sequenced Eklund-C BoNT/C phage genome displays features of a circular self-replicating episomal element: (i) the scaffolds bear no similarity to the C. novyi NT chromosomal sequence, (ii) it contains only one copy of a putative terminal direct repeat sequence that is spanned by numerous sequencing reads and is predicted to mediate circularization of the lysogen, as with the c-st phage (11), and (iii) the two halves of the Eklund-C phage sequence display distinctly different gene orientations and GC skews that diverge abruptly at the putative replication origin and terminus. The putative Eklund-C phage contains 198 predicted protein-coding genes or pseudogenes. Of these sequences, 135 and 99 were identified within the 08-BKT015925 and C-Stockholm phage genomes, respectively. Most conserved genes are found in syntenous blocks of sequence that are interspersed by novel regions encoding primarily hypothetical proteins. The most highly conserved phage genes include those within the BoNT operon (CBC_A0165-A0170), as well as several phage structural genes (12). BoNT/C- or BoNT/D-encoding phages typically carry a large number of insertion sequence (IS) elements (6). At least 12 intact or degraded IS elements were identified in the Eklund-C prophage, all of which belong to the IS200/605 family. Most of these are related to the elements observed in the 08-BKT015925 and C-Stockholm phages; however, the locations and copy numbers of many of these elements are varied.

Nucleotide sequence accession numbers.

The draft genome sequence for C. botulinum Eklund-C has been included in the GenBank Whole-Genome Shotgun (WGS) database under the accession no. ABDQ00000000. The version described is accession no. ABDQ00000000.1.
  12 in total

1.  Mauve: multiple alignment of conserved genomic sequence with rearrangements.

Authors:  Aaron C E Darling; Bob Mau; Frederick R Blattner; Nicole T Perna
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

Review 2.  Pseudolysogeny.

Authors:  Marcin Łoś; Grzegorz Węgrzyn
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

3.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

4.  The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Ken Kurokawa; Keisuke Nakayama; Kenshiro Oshima; Yukako Fujinaga; Makoto Ohnishi; Eiichi Ohtsubo; Masahira Hattori; Keiji Oguma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

5.  Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.

Authors:  M W Eklund; F T Poysky; J A Meyers; G A Pelroy
Journal:  Science       Date:  1974-11-01       Impact factor: 47.728

6.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

7.  Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.

Authors:  C M Fraser; S Casjens; W M Huang; G G Sutton; R Clayton; R Lathigra; O White; K A Ketchum; R Dodson; E K Hickey; M Gwinn; B Dougherty; J F Tomb; R D Fleischmann; D Richardson; J Peterson; A R Kerlavage; J Quackenbush; S Salzberg; M Hanson; R van Vugt; N Palmer; M D Adams; J Gocayne; J Weidman; T Utterback; L Watthey; L McDonald; P Artiach; C Bowman; S Garland; C Fuji; M D Cotton; K Horst; K Roberts; B Hatch; H O Smith; J C Venter
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

Review 8.  Biology and genomic analysis of Clostridium botulinum.

Authors:  Michael W Peck
Journal:  Adv Microb Physiol       Date:  2009       Impact factor: 3.517

9.  The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT.

Authors:  Chetan Bettegowda; Xin Huang; Jimmy Lin; Ian Cheong; Manu Kohli; Stephen A Szabo; Xiaosong Zhang; Luis A Diaz; Victor E Velculescu; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou
Journal:  Nat Biotechnol       Date:  2006-11-19       Impact factor: 68.164

10.  Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements.

Authors:  Hanna Skarin; Therese Håfström; Josefina Westerberg; Bo Segerman
Journal:  BMC Genomics       Date:  2011-04-12       Impact factor: 3.969

View more
  1 in total

1.  Plasmidome interchange between Clostridium botulinum, Clostridium novyi and Clostridium haemolyticum converts strains of independent lineages into distinctly different pathogens.

Authors:  Hanna Skarin; Bo Segerman
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.